DA Davidson Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLXFree Report) had its price objective increased by DA Davidson from $153.00 to $171.00 in a report issued on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. DA Davidson also issued estimates for Clorox’s Q2 2025 earnings at $1.27 EPS and FY2026 earnings at $6.61 EPS.

A number of other equities analysts have also commented on the company. Evercore ISI cut their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and increased their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Wells Fargo & Company decreased their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Barclays increased their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Finally, Citigroup upped their target price on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $155.00.

Read Our Latest Research Report on Clorox

Clorox Price Performance

Shares of NYSE:CLX opened at $162.70 on Monday. The firm has a 50 day moving average of $161.89 and a 200-day moving average of $146.58. The stock has a market capitalization of $20.14 billion, a PE ratio of 56.69, a PEG ratio of 3.11 and a beta of 0.41. Clorox has a 12 month low of $127.60 and a 12 month high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. The firm’s revenue was up 27.0% compared to the same quarter last year. On average, equities research analysts predict that Clorox will post 6.81 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.00%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On Clorox

Several hedge funds have recently bought and sold shares of CLX. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Clorox by 99.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,813 shares of the company’s stock worth $7,136,000 after buying an additional 22,882 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Clorox by 18.3% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,748 shares of the company’s stock valued at $574,000 after purchasing an additional 581 shares during the period. Fidelis Capital Partners LLC purchased a new position in Clorox during the 1st quarter worth $63,000. Nordea Investment Management AB boosted its holdings in shares of Clorox by 4.5% in the first quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock valued at $1,519,000 after acquiring an additional 426 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its holdings in Clorox by 44.2% during the first quarter. Daiwa Securities Group Inc. now owns 16,505 shares of the company’s stock worth $2,527,000 after acquiring an additional 5,056 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.